- Benzinga•4 months ago
OXiGENE, Inc. (Nasdaq: OXGN ) revealed the Food and Drug Administration has granted orphan drug status to its CA4P for the treatment of glioma. According to the company, the designation provided for seven ...
- Benzinga•7 months ago
Shares of OXiGENE Inc (NASDAQ: OXGN ), a nano-cap biopharmaceutical company that focuses on the treatment of cancer, spiked higher by 13 percent on Wednesday after the company announced that the U.S. Food ...
We're sorry this is all we were able to find about this topic.
NasdaqCM . Currency in USD
|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52wk Range||undefined - undefined|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||N/A|
|Avg Vol (3m)||N/A|
|Dividend & Yield||N/A (N/A)|